Genetic predisposition in anti‐LGI1 and anti‐NMDA receptor encephalitis
…, A Juranek, RD Kanitz, J Obrocki… - Annals of …, 2018 - Wiley Online Library
We performed a genome‐wide association study in 1,194 controls and 150 patients with anti‐N‐methyl‐D‐aspartate
receptor (anti‐NMDAR, n = 96) or anti‐leucine‐rich glioma‐…
receptor (anti‐NMDAR, n = 96) or anti‐leucine‐rich glioma‐…
A voxel-based PET investigation of the long-term effects of “Ecstasy” consumption on brain serotonin transporters
…, K Petersen, B Nebeling, J Obrocki… - American Journal of …, 2004 - Am Psychiatric Assoc
OBJECTIVE: Recent functional imaging studies have reported evidence of alterations in the
serotonergic system induced by 3,4-methylenedioxymethamphetamine (MDMA), or “Ecstasy.…
serotonergic system induced by 3,4-methylenedioxymethamphetamine (MDMA), or “Ecstasy.…
[HTML][HTML] Clinical manifestations and immunomodulatory treatment experiences in psychiatric patients with suspected autoimmune encephalitis: a case series of 91 …
…, K Winter, N Zumdick, A Drews, J Obrocki… - Molecular …, 2022 - nature.com
Autoimmune encephalitis (AE) can rarely manifest as a predominantly psychiatric syndrome
without overt neurological symptoms. This study’s aim was to characterize psychiatric …
without overt neurological symptoms. This study’s aim was to characterize psychiatric …
Long-term effects of “ecstasy” use on serotonin transporters of the brain investigated by PET
…, B Nebeling, K Petersen, J Obrocki… - Journal of Nuclear …, 2003 - Soc Nuclear Med
Alterations of the serotonergic system due to ecstasy consumption have been extensively
documented in recent literature. However, reversibility of these neurotoxic effects still remains …
documented in recent literature. However, reversibility of these neurotoxic effects still remains …
Ecstasy–long-term effects on the human central nervous system revealed by positron emission tomography
J Obrocki, R Buchert, O Väterlein… - The British Journal of …, 1999 - cambridge.org
BackgroundThe main psychotropic agent of the popular illicit drug ecstasy is 3,4-methylenedioxymethamphetamine
(MDMA). In the light of animal studies and examinations of human …
(MDMA). In the light of animal studies and examinations of human …
Effects of behavioral therapy or pharmacotherapy on brain glucose metabolism in subjects with obsessive–compulsive disorder as assessed by brain FDG PET
…, M Rufer, A Weiss, I Hand, M Clausen, J Obrocki - Psychiatry Research …, 2010 - Elsevier
This prospective study investigated the effect of pharmacotherapy (PT) and cognitive
behavioral therapy (CBT) on cerebral glucose metabolism in adults with obsessive–compulsive …
behavioral therapy (CBT) on cerebral glucose metabolism in adults with obsessive–compulsive …
Reversibility of ecstasy-induced reduction in serotonin transporter availability in polydrug ecstasy users
…, R Thomasius, K Petersen, F Wilke, J Obrocki… - European journal of …, 2006 - Springer
Purpose Animal data suggest that the synthetic drug ecstasy may damage brain serotonin
neurons. Previously we reported protracted reductions in the availability of the serotonin …
neurons. Previously we reported protracted reductions in the availability of the serotonin …
[PDF][PDF] Anhaltende neurotoxische Schaden durch Ecstasy
J Obrocki, B Andresen, A Schmoldt… - … Mitteilungen-Ausgabe A, 2001 - mikusweb.de
Der Missbrauch der synthetischen Droge Ecstasy ist in westlichen Industriestaaten weit
verbreitet und mittlerweile zu einem gesundheitspolitischen Problem geworden. Neben den von …
verbreitet und mittlerweile zu einem gesundheitspolitischen Problem geworden. Neben den von …
Cell surface antibody–associated neurodegeneration: The case of anti-IgLON5 antibodies
RC Dale, S Ramanathan - Neurology, 2017 - AAN Enterprises
Cell surface autoantibodies have become important biomarkers of acquired autoimmune
CNS disorders, and typically define potentially severe but treatable acquired autoimmune …
CNS disorders, and typically define potentially severe but treatable acquired autoimmune …
IgLON5: a case with predominant cerebellar tau deposits and leptomeningeal inflammation
In 2014, a novel tauopathy characterized by REM sleep behavior disorder (RBD), sleep apnea,
and stridor was first reported. Association with serum and CSF antibodies against IgLON5…
and stridor was first reported. Association with serum and CSF antibodies against IgLON5…